Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-6511
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials ; volume:17 ; number:1 ; day:10 ; month:3 ; year:2016 ; pages:1-15 ; date:12.2016
BMC pharmacology & toxicology ; 17, Heft 1 (10.3.2016), 1-15, 12.2016
- Creator
-
Wiśniowska, Barbara
Tylutki, Zofia
Wyszogrodzka, Gabriela
Polak, Sebastian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40360-016-0053-1
- URN
-
urn:nbn:de:101:1-2019070521190214518329
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wiśniowska, Barbara
- Tylutki, Zofia
- Wyszogrodzka, Gabriela
- Polak, Sebastian
- SpringerLink (Online service)
Other Objects (12)
Identifying potential drugs that induce QT prolongation using electronic medical records
Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice
The Role of Interaction Model in Simulation of Drug Interactions and QT Prolongation
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Case report: Medical cannabis—warfarin drug-drug interaction
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Identifying potential drugs that induce QT prolongation using electronic medical records
Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice
The Role of Interaction Model in Simulation of Drug Interactions and QT Prolongation
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Case report: Medical cannabis—warfarin drug-drug interaction
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Identifying potential drugs that induce QT prolongation using electronic medical records
Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice
The Role of Interaction Model in Simulation of Drug Interactions and QT Prolongation
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Case report: Medical cannabis—warfarin drug-drug interaction
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions